sorafenib sandoz 200 mg tabletki powlekane
sandoz gmbh - sorafenibi tosilas - tabletki powlekane - 200 mg
sorafenib sandoz 400 mg tabletki powlekane
sandoz gmbh - sorafenibi tosilas - tabletki powlekane - 400 mg
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - Środki przeciwnowotworowe - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
sorafenib stada 200 mg tabletki powlekane
stada arzneimittel ag - sorafenibum - tabletki powlekane - 200 mg
sorafenib stada 400 mg tabletki powlekane
stada arzneimittel ag - sorafenibi tosilas - tabletki powlekane - 400 mg
sorafenib mylan 200 mg tabletki powlekane
mylan ireland limited - sorafenibum - tabletki powlekane - 200 mg
sorafenib alvogen 200 mg tabletki powlekane
alvogen pharma trading europe eood - sorafenibi tosilas - tabletki powlekane - 200 mg
sorafenib g.l. 200 mg tabletki powlekane
g.l. pharma gmbh - sorafenibi tosilas - tabletki powlekane - 200 mg
sorafenib zentiva 200 mg tabletki powlekane
zentiva, k.s. - sorafenibi tosilas - tabletki powlekane - 200 mg
sorafenib pharmascience 200 mg tabletki powlekane
pharmascience international limited - sorafenibum - tabletki powlekane - 200 mg